期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Extracranial Metastasis of an Anaplastic Ependymoma, RELA Fusion-Positive: A Rare Occurrence
1
作者 Christine Milena Sayore Nabil Adio Mousse +3 位作者 Mohammed Yassaad Oudrhiri Nadia Cherradi Adyl Melhaoui Abdessamad El Ouahabi 《Open Journal of Modern Neurosurgery》 2020年第1期9-18,共10页
Primary intracranial ependymomas originate from ependymal cells. They may migrate mainly in the spinal cord but rarely metastasize outside the central nervous system. Metastases outside the central nervous system are ... Primary intracranial ependymomas originate from ependymal cells. They may migrate mainly in the spinal cord but rarely metastasize outside the central nervous system. Metastases outside the central nervous system are rare. Metastatic diffusion from the central nervous system is low due to the unique interaction of the brain and the tumor with the blood-brain barrier. Nevertheless, three main hypotheses have been mentioned in the literature, the tumor growth, the surgical manipulation (which may be considered to be the case in our patient), and the aggressiveness of the tumor according to the Ki67 index. We report the case of a 16-year-old female, who underwent complete surgical removal of a left occipital 2007 WHO grade II ependymoma. 3 years later, the patient presented multiple cervical and occipital indurated masses. MRI showed a left hemispheric meningeal infiltration, with multiple nodules located on the neck, occiput and mastoid. Histopathological study of a left temporal surgical biopsy and resection of an occipital subcutaneous nodule turned to be metastases of an anaplastic ependymoma. The ependymoma considered as a benign tumor could very quickly turn into malignancy by its metastatic potential. Early diagnosis and longer follow-up of patients would be recommended for a rapid management. 展开更多
关键词 ANAPLASTIC EPENDYMOMA EXTRACRANIAL Metastasis Extraneural rela fusion
下载PDF
Lipomatous ependymoma with ZFTA:RELA fusion-positive:A case report
2
作者 Xiao-Yu Zhao Juan-Han Yu +4 位作者 Yi-Hua Wang Yi-Xin Liu Lu Xu Lin Fu Ning Yi 《World Journal of Clinical Cases》 SCIE 2025年第1期48-55,共8页
BACKGROUND Ependymoma with lipomatous differentiation is a rare type of ependymoma.The ZFTA fusion-positive supratentorial ependymoma is a novel tumor type in the 2021 World Health Organization classification of centr... BACKGROUND Ependymoma with lipomatous differentiation is a rare type of ependymoma.The ZFTA fusion-positive supratentorial ependymoma is a novel tumor type in the 2021 World Health Organization classification of central nervous system tumors.ZFTA fusion-positive lipomatous ependymoma has not been reported to date.CASE SUMMARY We reported a case of a 15-year-old Chinese male who had a sudden convulsion lasting approximately six minutes.Magnetic resonance imaging showed a round cystic shadow of approximately 1.9 cm×1.5 cm×1.9 cm under the right parieto-occipital cortex.Microscopic examination showed characteristic perivascular pseudorosettes and adipose differentiation in the cytoplasm.Immunohisto-chemical staining showed that the tumor cells were negative for cytokeratin,NeuN,Syn and p53,but positive for GFAP,vimentin and S-100 protein.Signi-ficant punctate intracytoplasmic EMA immunoreactivity was observed.The level of Ki-67 was about 5%.Genetic analysis revealed ZFTA:RELA fusion.A cranio-tomy with total excision of the tumor was performed.The follow-up time was 36 months,no evidence of disease recurrence was found in magnetic resonance imaging.CONCLUSION Based on these findings,the patient was diagnosed as a ependymoma with ZFTA fusion and lipomatous differentiation.This case report provides information on the microscopic morphological features of ependymoma with ZFTA fusion and lipomatous differentiation,which can help pathologists to make a definitive diagnosis of this tumor. 展开更多
关键词 Ependymoma Lipomatous Molecular classification Supratentorial ZFTA:rela fusion Case report
下载PDF
RELA融合基因阳性室管膜瘤11例临床病理分析 被引量:4
3
作者 张安莉 孙思柏 +1 位作者 李恒 吴海波 《临床与实验病理学杂志》 CAS CSCD 北大核心 2019年第1期33-37,共5页
目的探讨RELA融合基因阳性室管膜瘤的临床病理学特征。方法回顾性分析11例RELA融合基因阳性室管膜瘤的临床资料、影像学特点、病理学特征和免疫表型,并复习相关文献。结果 11例RELA融合基因阳性室管膜瘤均位于幕上,男性6例、女性5例,发... 目的探讨RELA融合基因阳性室管膜瘤的临床病理学特征。方法回顾性分析11例RELA融合基因阳性室管膜瘤的临床资料、影像学特点、病理学特征和免疫表型,并复习相关文献。结果 11例RELA融合基因阳性室管膜瘤均位于幕上,男性6例、女性5例,发病年龄3~56岁,平均27岁。影像学示幕上占位性病变。镜下见分支状毛细血管网和真/假菊形团结构。免疫表型:瘤细胞GFAP、L1CAM、Cyclin D1均呈弥漫阳性,EMA呈核旁点状阳性,多数病例表达nestin,Olig-2均阴性。结论RELA融合基因阳性室管膜瘤好发于年轻人的幕上,具有独特的免疫表型和基因表型,预后较差,需进行诊断与鉴别诊断。 展开更多
关键词 室管膜瘤 rela融合基因 L1CAM 免疫组织化学
下载PDF
13例RELA基因融合型室管膜瘤临床病理分析
4
作者 侯静 陈铌 +6 位作者 郑林茂 谭珺娅 龚静 钟金晶 苏征征 卫昱燕 周桥 《诊断病理学杂志》 2021年第7期552-556,561,共6页
目的探讨RELA基因融合型室管膜瘤的临床病理特征及分子改变。方法回顾性分析四川大学华西医院2017—2020年确诊的13例RELA基因融合型室管膜瘤,总结其临床表现、病理特征、分子遗传学改变及预后情况。结果本组病例包括男性7例,女性6例。... 目的探讨RELA基因融合型室管膜瘤的临床病理特征及分子改变。方法回顾性分析四川大学华西医院2017—2020年确诊的13例RELA基因融合型室管膜瘤,总结其临床表现、病理特征、分子遗传学改变及预后情况。结果本组病例包括男性7例,女性6例。患者年龄9.0月~39.0岁,平均年龄18.0岁,中位年龄21.0岁。13例肿瘤均位于幕上,平均直径5.6 cm。患者临床多表现为头痛、呕吐。影像学显示实性或囊实性团块状混杂密度影,可见出血及钙化,肿物周边可见水肿带。镜下见肿瘤细胞密度较高,核分裂易见,增生、玻璃样变性的分支状血管分割肿瘤细胞呈网状。除典型的室管膜瘤细胞形态外,还可见胞质透明的“少突样细胞”、怪异核细胞、瘤巨细胞等。10例可见肿瘤性凝固性坏死,6例可见钙化灶形成。12/13例(92.3%)组织学为WHO 3级。免疫组化方面,EMA呈核旁点状模式,GFAP常表现为血管周阳性模式,8/13例(61.5%)肿瘤细胞局灶表达olig-2,未见ATRX缺失及IDH1突变。FISH检测13例肿瘤均检出RELA基因分离信号。13例均获得随访资料,中位随访时间23.0月。5例于术后12.0~72.0月复发,其中2例多次复发。结论 RELA基因融合型室管膜瘤好发于幕上,主要见于儿童及年轻成人,其组织形态多样,具有特征性的分子遗传学改变,需与少突胶质细胞瘤、胶质母细胞瘤、中枢神经细胞瘤及髓母细胞瘤鉴别。此类肿瘤组织学级别较高,肿瘤易复发,患者预后相对较差,需要与普通室管膜瘤进行区别。发生在幕上的室管膜瘤建议常规进行RELA融合基因检测。 展开更多
关键词 室管膜瘤 rela基因融合 FISH 预后
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部